NCT06559488View on ClinicalTrials.gov

IVB for Post-vitrectomy Hemorrhage in Diabetic Eyes

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

April 2, 2018

Primary Completion Date

March 31, 2019

Study Completion Date

March 31, 2019

Conditions
Diabetic RetinopathyVitreous Hemorrhage
Interventions
DRUG

Bevacizumab Injection [Avastin]

Intravitreal bevacizumab (1.25 mg/0.05 mL) was injected at the completion of vitrectomy surgery.

PROCEDURE

Pars Plana Vitrectomy

routine procedure of pars plana vitrectomy in vitreous hemorrhage for proliferative diabetic retinopathy patients

Trial Locations (1)

40117

Cicendo Eye Hospital, Bandung

All Listed Sponsors
collaborator

Cicendo Eye Hospital

UNKNOWN

lead

Universitas Padjadjaran

OTHER

NCT06559488 - IVB for Post-vitrectomy Hemorrhage in Diabetic Eyes | Biotech Hunter | Biotech Hunter